CPT code 86337: Insulin antibodies, antibodies directed at insulin2026 Medicare lab fee · Clinical Laboratory Fee Schedule

Reports a laboratory measurement of antibodies directed against insulin, distinguishing this assay from tests measuring insulin concentration or antibodies to islet cells.

CMS CLFS 2026 Q4Effective Oct 1, 2026Same amount nationwide9.7K Medicare services in 2024

Medicare pays $21.41 for 86337 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.

Medicare lab fee · CLFS 2026 Q4

National CLFS amount

$21.41

In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.

Geographic adjustment
None
Office vs facility
Same
Since 2020
Unchanged
CMS updates
Quarterly

Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.

On this page 7 sections
  1. Medicare lab fee
  2. What 86337 covers
  3. How it’s paid
  4. Amount history
  5. Similar tests
  6. Billing questions
  7. Sources

What 86337 covers

86337 identifies measurement of antibodies directed against insulin. Insulin is the target being measured; this is distinct from measuring insulin concentration or testing for antibodies against islet cells. The service is a laboratory assay, and the reported result concerns insulin antibodies rather than another antibody target.

Report 86337 for the insulin-antibody measurement performed. Medicare pays it under the CLFS at one national amount per code in every state and locality, with no geographic adjustment and no office-versus-facility difference. The 2026 national CLFS amount is $21.41, unchanged in each listed year from 2020 through 2026. The test is paid through the CLFS only, rather than the physician fee schedule.

This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.

How Medicare pays 86337

Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.

One national amount

CMS sets a single Clinical Laboratory Fee Schedule amount for 86337. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.

No office or facility rate

Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.

Updated every quarter

CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.

Excluded from the physician fee schedule

The physician fee schedule lists 86337 with status X (excluded by statute), so the test itself is paid only from the CLFS.

86337 on the lab fee schedule since 2020

86337 · CLFS 2026 Q4 (current)

$21.41

Unchanged since Jan 1, 2020

Amount in each year’s latest CLFS release · bars start at $0

27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.

86337 compared with similar tests

86341Islet cell antibodyPancreatic islet antibodies$23.57
Use 86337 for antibodies directed against insulin; use 86341 for antibodies directed against islet cells.
83525Insulin assayTotal insulin$11.43
Code 83525 measures insulin concentration, while 86337 measures antibodies directed against insulin.
84681C-peptideEndogenous insulin marker$20.81
Code 84681 measures C-peptide, not insulin antibodies. Select the code that matches the laboratory analyte.

86337 billing questions

How does 86337 differ from islet cell antibody testing?

Code 86337 measures antibodies directed against insulin. Code 86341 measures antibodies directed against islet cells.

Is 86337 an insulin concentration test?

No. It measures insulin antibodies; code 83525 measures insulin concentration.

What should documentation identify?

Documentation should identify the test as measuring antibodies directed against insulin, rather than insulin concentration or antibodies to another target.

How does Medicare pay for 86337?

Medicare pays it under the CLFS at one national amount per code across localities, with no office-versus-facility difference.

Where this amount comes from

FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.

CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027

Show the CMS file line behind this amount
CLFS row for 86337PUF_CLFS_CY2026_Q4V1.csv, line 1,695 (CLFS 2026 Q4)

Open CMS sourceHow we source rates

Did this answer your question about what Medicare pays for 86337?

Tell us what you were actually trying to work out. We’ll answer you directly, or build the page that does.

Fee sheets · Coming soon

Put 86337 and the rest of your codes on one sheet

Your codes at your locality, with payer contracts beside Medicare.

Join the waitlist